Sold by: Modus CreateÂ
Build an AWS-powered RWE analytics pipeline to accelerate drug safety monitoring and biomarker discovery.
Overview
Pharmaceutical companies and CROs struggle to analyze real-world evidence (RWE) data from EHRs, claims data, and post-market surveillance due to fragmented systems and compliance concerns. This 4-week POC builds a secure, AWS-native data pipeline that aggregates, structures, and analyzes RWE datasets using AI-driven insights.
**What’s Included: **
- AWS Data Pipeline Setup – Configure Amazon Redshift & AWS HealthLake to ingest RWE data. •*AI-Powered Analytics Model – Use SageMaker to extract insights from unstructured datasets.
- Dashboard & Reporting – Deliver a working visualization of key drug safety metrics.
- Next Steps Roadmap – AWS adoption plan for scaling to full production.
Highlights
- AWS-Ready RWE Pipeline – Automates ingestion & analysis of clinical data for faster insights.
- HIPAA & GxP-Compliant Analytics – Ensures data governance meets regulatory standards.
- AI-Driven Insights for Drug Safety – Identifies safety signals & biomarker correlations.
Details
Sold by
Delivery method
Deployed on AWS
Unlock automation with AI agent solutions
Fast-track AI initiatives with agents, tools, and solutions from AWS Partners.
Pricing
Custom pricing options
Pricing is based on your specific requirements and eligibility. To get a custom quote for your needs, request a private offer.
Legal
Content disclaimer
Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.